Skip to main content
. 2004 Jun;164(6):1901–1913. doi: 10.1016/S0002-9440(10)63751-0

Figure 5.

Figure 5

The specificity of the cleavage of the caspase-sensitive CFP-LEVD-YFP probe by individual caspases was determined using specific caspase inhibitors. A: Hela cells were incubated with various caspase inhibitors as indicated, then were transfected with the caspase-sensitive probe, and analyzed for FRET assay by flow cytometry. A FRET-positive population and a population with diminished FRET were gated in R3 and R4, respectively. The mean fluorescence intensities (MFI) and percentage of each population compared to all gated CFP/YFP double-positive cells are shown in each panel. To quantitate caspase activity (CAf) by flow cytometry, caspase activity was calculated by the formula: CAf = (FRETbright − FRETdim)/FRETbright × 100 × FRETdim, where FRETbright and FRETdim are the mean fluorescence intensities of FRET in the FRETbright cells and the cells with diminished FRET, respectively; and where %FRETdim is the percentage of cells with diminished FRET among all transfected cells. B: The FRET-based caspase activity in living cells when incubated with specific caspase inhibitors.